December 2, 2022
Loading...
You are here:  Home  >  Latest news  >  Current Article

Stellar reports decline in third quarter earnings

IN THIS ARTICLE

Stellar Biotechnologies reported a 7 percent drop in revenue for the third quarter, and net losses stayed flat at $5.03 million. Shares shot up after the announcement Nov. 30 and continued to climb in after-hours trading to $1.15, up more than 12 percent. The Port Hueneme company, which manufactures keyhole limpet hemocyanin proteins for immunotherapies,…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.